DK0869813T3 - Anvendelse af beta-interferoner til behandling af restenose - Google Patents

Anvendelse af beta-interferoner til behandling af restenose

Info

Publication number
DK0869813T3
DK0869813T3 DK96940704T DK96940704T DK0869813T3 DK 0869813 T3 DK0869813 T3 DK 0869813T3 DK 96940704 T DK96940704 T DK 96940704T DK 96940704 T DK96940704 T DK 96940704T DK 0869813 T3 DK0869813 T3 DK 0869813T3
Authority
DK
Denmark
Prior art keywords
restenosis
treatment
beta interferons
beta
interferons
Prior art date
Application number
DK96940704T
Other languages
English (en)
Inventor
Anthony Johns
Robert J Mintzer
Original Assignee
Berlex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlex Lab filed Critical Berlex Lab
Application granted granted Critical
Publication of DK0869813T3 publication Critical patent/DK0869813T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96940704T 1995-11-30 1996-11-28 Anvendelse af beta-interferoner til behandling af restenose DK0869813T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/565,701 US5681558A (en) 1995-11-30 1995-11-30 Method of using beta-interferons to treat restenosis

Publications (1)

Publication Number Publication Date
DK0869813T3 true DK0869813T3 (da) 2006-01-02

Family

ID=24259751

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96940704T DK0869813T3 (da) 1995-11-30 1996-11-28 Anvendelse af beta-interferoner til behandling af restenose

Country Status (11)

Country Link
US (1) US5681558A (da)
EP (1) EP0869813B1 (da)
JP (2) JP4116075B2 (da)
AT (1) ATE303158T1 (da)
AU (1) AU712960B2 (da)
CA (1) CA2238871C (da)
DE (1) DE69635131T2 (da)
DK (1) DK0869813T3 (da)
ES (1) ES2247607T3 (da)
WO (1) WO1997019697A1 (da)
ZA (1) ZA9610073B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866561A (en) * 1997-08-21 1999-02-02 Scimed Life Systems, Inc. Local delivery of estrogen for angiogenesis
US7018371B2 (en) * 2001-05-07 2006-03-28 Xoft, Inc. Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia
US6537195B2 (en) 2001-05-07 2003-03-25 Xoft, Microtube, Inc. Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasia
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
SE462364B (sv) * 1988-09-30 1990-06-18 Goeran Hansson Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos
JPH04116075A (ja) * 1990-09-03 1992-04-16 Hitachi Building Syst Eng & Service Co Ltd エレベータの乗り場報知装置
CA2153158A1 (en) * 1993-01-07 1994-07-21 Andrew Zalewski Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells
US6780406B1 (en) * 1994-03-21 2004-08-24 The Regents Of The University Of Michigan Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene
WO1997018831A1 (fr) * 1995-11-17 1997-05-29 Toray Industries, Inc. Protection des cellules endotheliales

Also Published As

Publication number Publication date
US5681558A (en) 1997-10-28
EP0869813B1 (en) 2005-08-31
ZA9610073B (en) 1997-06-18
EP0869813A1 (en) 1998-10-14
WO1997019697A1 (en) 1997-06-05
ES2247607T3 (es) 2006-03-01
ATE303158T1 (de) 2005-09-15
CA2238871C (en) 2006-08-15
AU1070397A (en) 1997-06-19
EP0869813A4 (en) 2003-02-05
JP4116075B2 (ja) 2008-07-09
JP2008031179A (ja) 2008-02-14
AU712960B2 (en) 1999-11-18
DE69635131D1 (de) 2005-10-06
DE69635131T2 (de) 2006-07-06
CA2238871A1 (en) 1997-06-05
JP2000501093A (ja) 2000-02-02

Similar Documents

Publication Publication Date Title
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
TR28718A (tr) Dinamik takilan tipte cocuk bezi.
PT797439E (pt) Utilizacao de pramipexote como agente neuroprotector
ES2137554T3 (es) 2-(2-amino-3-metoxifenil)-4-oxo-4h-(1)benzopirano para el tratamiento de desordenes proliferantes.
ES2154253T1 (es) Inhibicion de la actividad de la quinasa p38 utilizando ureas heterociclicas sustituidas.
ES2155817T1 (es) Inhibicion de la actividad de la quinasa p38 utilizando ureas heterociclicas sustituidas con arilo y heteroarilo.
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DK0786991T3 (da) Polyaminforbindelsre til behandling af proliferative karsygdomme
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
DE69841041D1 (de) Stent beschichtet mit dna
DK73891D0 (da) Enzymbehandling
BR9101494A (pt) Tratamento de tecidos
DK0869813T3 (da) Anvendelse af beta-interferoner til behandling af restenose
MX9304626A (es) Derivados heterociclicos utiles en el tratamiento de enfermedades cardiovasculares.
NO905291L (no) Fremgangsmaate for behandling av sinkholdige biprodukter og avfallsmaterialer.
LV10574A (lv) Trinitrobenzolu vai karminskabes pielietosana veza vai virali slimibu arstesana
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
NO995539L (no) Anvendelse av hepariner med lav molekylvekt for prevensjon og terapi av cerebrale ödemer
DK0578702T3 (da) Middel til behandling af huden hos dyr
TR199800850T2 (xx) Kan� d�zenleyici bile�imler.
DE69117566D1 (de) Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen
BA95039A (bs) Set za prevenciju i terapiju bolne menstruacije